
  
    
      
        
        A_DT link_NN between_IN high_JJ levels_NNS of_IN homocysteine_NN ,_, a_DT sulfur-containing_JJ amino_JJ acid_NN ,_, and_CC heart_NN
        disease_NN was_VBD first_RB suggested_VBD in_IN the_DT 1960_CD s_VBZ ,_, when_WRB it_PRP became_VBD clear_JJ that_IN patients_NNS with_IN inborn_NN
        errors_NNS of_IN homocysteine_NN metabolism_NN were_VBD prone_JJ to_TO develop_VB severe_JJ cardiovascular_JJ disease_NN in_IN
        their_PRP$ teens_NNS and_CC twenties_NNS ._. Treatment_NNP with_IN homocysteine-lowering_JJ substances_NNS such_JJ as_IN folate_NN ,_,
        vitamin_NN B_NNP 12_CD ,_, and_CC betaine_NN reduces_VBZ the_DT incidence_NN of_IN heart_NN attacks_NNS and_CC strokes_NNS in_IN these_DT
        patients_NNS ._.
        This_DT led_VBN to_TO the_DT hypothesis_NNS that_WDT mildly_RB elevated_VBD levels_NNS of_IN homocysteine_NN might_MD contribute_VB
        to_TO vascular_NN disease_NN ._. Subsequently_RB ,_, several_JJ studies_NNS have_VBP found_VBN higher_JJR mean_NN homocysteine_NN
        levels_NNS in_IN patients_NNS with_IN coronary_JJ ,_, peripheral_JJ ,_, and_CC cerebral_JJ vascular_NN disease_NN ,_, particularly_RB
        in_IN those_DT with_IN vascular_NN disease_NN not_RB readily_RB explained_VBN by_IN conventional_JJ risk_NN factors_NNS such_JJ as_IN
        high_JJ low-density_NN lipoprotein_NN (_( LDL_NNP )_) cholesterol_NN ,_, diabetes_NN ,_, or_CC smoking_NN ._. Several_JJ studies_NNS then_RB
        sought_VBN to_TO determine_VB whether_IN elevated_JJ homocysteine_NN levels_NNS were_VBD a_DT cause_NN or_CC effect_VB of_IN
        cardiovascular_JJ disease_NN ,_, and_CC evidence_NN for_IN a_DT causal_NN relationship_NN is_VBZ accumulating_VBG ._. However_RB ,_,
        whether_IN reduction_NN in_IN homocysteine_NN levels_NNS translates_NNS into_IN a_DT reduction_NN in_IN heart_NN disease_NN is_VBZ
        still_RB an_DT open_JJ question_NN ._.
        “ We_PRP are_VBP keenly_RB awaiting_VBG the_DT results_NNS from_IN several_JJ ongoing_JJ trials_NNS ._. In_IN the_DT meantime_NN ,_, our_PRP$
        group_NN is_VBZ trying_VBG to_TO determine_VB the_DT risks_NNS and_CC benefits_NNS associated_VBN with_IN different_JJ
        homocysteine-lowering_JJ nutrients_NNS ,_,” said_VBD Margreet_NNP Olthof_NNP ._. She_PRP and_CC her_PRP$ colleagues_NNS at_IN the_DT
        Wageningen_NNP Centre_NNP for_IN Food_NNP Science_NNP analyzed_VBD four_CD independent_JJ ,_, placebo-controlled_JJ ,_,
        randomized_JJ intervention_NN studies_NNS that_WDT examined_VBD the_DT effects_NNS of_IN betaine_NN ,_, folic_JJ acid_NN ,_, and_CC
        phosphatidylcholine_NN on_IN plasma_NN homocysteine_NN concentrations_NNS in_IN healthy_JJ volunteers_NNS ._. They_PRP
        combined_VBD blood_NN lipid_NN data_NNS from_IN the_DT individual_JJ studies_NNS and_CC compared_VBN changes_NNS in_IN blood_NN lipid_NN
        concentrations_NNS between_IN individuals_NNS taking_VBG homocysteine-lowering_JJ nutrients_NNS and_CC those_DT taking_VBG
        placebo_NN ._.
        They_PRP found_VBD that_IN that_DT betaine_NN supplementation_NN ,_, while_IN effective_JJ at_IN lowering_VBG homocysteine_NN ,_,
        also_RB increased_VBN LDL_NNP cholesterol_NN and_CC triacylglycerol_NN ._.
        This_DT raises_VBZ the_DT possibility_NN that_IN any_DT potential_JJ benefits_NNS for_IN cardiovascular_JJ health_NN would_MD
        be_VB undermined_VBN by_IN the_DT adverse_JJ effects_NNS on_IN blood_NN lipids_NNS ,_, and_CC make_VB betaine_NN less_RBR suitable_JJ as_IN a_DT
        homocysteine-lowering_JJ agent_NN in_IN healthy_JJ individuals_NNS ._. The_DT data_NNS on_IN phosphatidylcholine_NN were_VBD
        inconclusive_JJ ,_, but_CC supplementation_NN of_IN folic_JJ acid—the_NN most_RBS common_JJ way_NN to_TO lower_JJR homocysteine_NN
        levels—does_NNS not_RB seem_VB to_TO affect_VB blood_NN lipids_NNS ._. The_DT researchers_NNS conclude_VBP that_IN folic_JJ acid_NN
        “ therefore_RB remains_VBZ the_DT preferred_JJ treatment_NN for_IN lowering_VBG of_IN blood_NN homocysteine_NN
        concentrations_NNS” in_IN healthy_JJ individuals_NNS ._.
      
    
  
